Concordia International Announces Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
RBC Capital Downgrades Concordia Healthcare (CXRX) to Sector Perform
November 8, 2016 6:20 AM ESTRBC Capital downgraded Concordia Healthcare (NASDAQ: CXRX) from Outperform to Sector Perform with a price target of $2.50 (from $10.00) as the US Legacy business significantly underperformed largely due to pricing issues.
Analyst Douglas Miehm commented, "are downgrading Concordia to Sector perform as we believe risks are increasing materially and visibility is worsening. In... More
Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Sell
November 7, 2016 1:24 PM ESTCanaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Spec. Buy to Sell with a price target of $1.00.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $3.19 yesterday.
... More